Hansen Gwenn
SEC insider (Form 3/4/5 filer). CIK 0001817160. Chief Scientific Officer at Nurix Therapeutics, Inc. (NRIX). 52 reported Form 4/5 transactions since Sep 2024; latest on Oct 15, 2026. Located in BRISBANE, CA.
Companies Hansen Gwenn has filed insider reports for
- Nurix Therapeutics, Inc. (NRIX): Officer, Chief Scientific Officer
Hansen Gwenn
CIK: 0001817160
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Nurix Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (52 total)
- Oct 15, 2026NRIX
Nurix Therapeutics, Inc.
SaleDirect1.5K shares at avg. $25.00$36K - Oct 15, 2026NRIX
Nurix Therapeutics, Inc.
ExerciseDirect1.5K shares at avg. $1.86$3K - Sep 1, 2026NRIX
Nurix Therapeutics, Inc.
SaleDirect1.5K shares at avg. $25.47$37K - Sep 1, 2026NRIX
Nurix Therapeutics, Inc.
ExerciseDirect1.5K shares at avg. $1.86$3K - Aug 5, 2026NRIX
Nurix Therapeutics, Inc.
ExerciseDirect4.4K shares at avg. $1.86$8K - Aug 5, 2026NRIX
Nurix Therapeutics, Inc.
SaleDirect4.4K shares at avg. $25.00$109K - Aug 4, 2026NRIX
Nurix Therapeutics, Inc.
SaleDirect1.5K shares at avg. $23.87$36K - Aug 4, 2026NRIX
Nurix Therapeutics, Inc.
SaleDirect2.6K shares at avg. $24.64$64K - Jul 30, 2026NRIX
Nurix Therapeutics, Inc.
ExerciseDirect2.9K shares- - Jul 30, 2026NRIX
Nurix Therapeutics, Inc.
SaleDirect3.8K shares at avg. $23.38$90K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 15, 2026 | NRIX Nurix Therapeutics, Inc. | Sale | 1,452 | $25.00 | $36,300 | Direct |
| Oct 15, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise | 1,452 | $1.86 | $2,701 | Direct |
| Sep 1, 2026 | NRIX Nurix Therapeutics, Inc. | Sale | 1,452 | $25.47 | $36,982 | Direct |
| Sep 1, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise | 1,452 | $1.86 | $2,701 | Direct |
| Aug 5, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise | 4,356 | $1.86 | $8,102 | Direct |
| Aug 5, 2026 | NRIX Nurix Therapeutics, Inc. | Sale | 4,356 | $25.00 | $108,900 | Direct |
| Aug 4, 2026 | NRIX Nurix Therapeutics, Inc. | Sale | 1,500 | $23.87 | $35,803 | Direct |
| Aug 4, 2026 | NRIX Nurix Therapeutics, Inc. | Sale | 2,611 | $24.64 | $64,339 | Direct |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | Exercise | 2,858 | - | $0 | Direct |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | Sale | 3,847 | $23.38 | $89,954 | Direct |
1-10 of 52 transactions